Pharmacology

Action Mechanism of Action Reference
RNAI INHIBITOR PCSK9 mRNA rnai inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Atherosclerosis 4 D050197 FDA
Hyperlipoproteinemia Type II 4 D006938 FDA